Pharmaxis is an Australian biotechnology company committed to research and drug development in diseases involving inflammation and fibrosis including cystic fibrosis, pulmonary fibrosis and liver disease.
Bronchitol® (mannitol) is a therapeutic agent manufactured by Pharmaxis and approved in numerous markets worldwide. For information specific to your country, please choose from the dropdown box.
Pharmaxis Corporate Website click here
Distributors/Partners click here for Brand Resources
For EU countries not listed in the dropdown box click here